172
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Combined immunophenotyping and fluorescence in situ hybridization with chromosome-specific DNA probes allows quantification and differentiation of ex vivo generated dendritic cells, leukemia-derived dendritic cells and clonal leukemic cells in patients with acute myeloid leukemia

, , , , , , , & show all
Pages 1297-1308 | Received 25 Jul 2012, Accepted 15 Nov 2012, Published online: 26 Dec 2012
 

Abstract

Antileukemic T-cell responses induced by leukemia-derived dendritic cells (DCleu) are variable, due to varying DC/DCleu composition/quality. We studied DC/DCleu composition/quality after blast culture in four DC media by flow cytometry (FC) and combined fluorescence in situ hybridization/immunophenotyping analysis (FISH-IPA). Both methods showed that DC methods produce variable proportions of DC subtypes. FISH-IPA is an elaborate method to study clonal aberrations in blast/DC cells on slides, however without preselection of distinct cell populations for FISH analysis. FISH-IPA data proved previous FC data: not every clonal/blast cell is converted to DCleu (resulting in various proportions of DCleu) and not every detectable DC is of clonal/leukemic origin. Preselection of the best of four DC methods for “best” DC/DCleu generation is necessary. DCleu proportions correlate with the antileukemic functionality of DC/DCleu-stimulated T-cells, thereby proving the necessity of studying the quality of DC/DCleu after culture. FC is the superior method to quantify DC/DCleu, since a blast phenotype is available in every given patient, even with low/no proportions of clonal aberrations, and can easily be used to study cellular compositions after DC culture.

Acknowledgements

The authors thank nurses and physicians on the wards for their support, and diagnostic laboratories for the contribution of diagnostic reports of the patients. Part of the results presented in this manuscript were determined in the course of the MD theses of Andreas Kremser and Stefanie Kufner at the University of Munich, Department of Hematopoietic Transplantations of the Ludwig-Maximilian-University of Munich and the Helmholtz-Center Munich.

Potential conflict of interest:

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.